Leveraging the Insights Gained from TIL Therapy to Improve TCR-T

Time: 3:00 pm
day: Day One


  • Exploring the success of TIL therapy in the context of solid tumors and how it has addressed the issue of tumor heterogeneity
  • How to leverage TCR therapies across a population in terms of diversity?
  • How to address tumor heterogeneity with regards to solid tumor efficacy?